Table 2 Patients with acquired Gerbode defect undergoing previous cardiac surgery
Author | Year | Gender | Age | Diagnostic tool | Previous procedure | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
1. Katta et al. | 1994 | Male | 54 | TTE,TEE | Endomyocardial biopsy | Conservative | Survived |
2. Dzwonczyk et al. | 1995 | Male | 25 | TTE | ASD repair | na | na |
3. Dzwonczyk et al. | 1995 | Female | 72 | TTE | AVR, VSD repair | na | na |
4. Fukui et al. | 2000 | Male | 53 | TEE | MVR x 2 | Surgery | Survived |
5. Benisty et al. | 2000 | Male | 72 | TTE, TEE | MVR | Surgery | n.a. |
6. Benisty et al. | 2000 | Male | 73 | TTE, TEE | MVR x 3, AVR | Surgery | n.a. |
7. Weinrich et al. | 2001 | Female | 58 | TEE, CC | MVRx 2 | Surgery | Survived |
8. Wasserman et al. | 2002 | Male | 78 | TTE, TEE, | AVR | Surgery | Survived |
9. Cabalka et al. | 2005 | Female | 70 | TTE, TEE | MVR x 2 | Percutaneous | Survived |
10. Lorber et al. | 2006 | Female | 78 | TTE, CC | MVR | Percutaneous | Survived |
11. Ramasubbu et al. | 2006 | Male | 41 | TEE | Aortic root reconstruction | Surgery | Survived |
12. Ramasubbu et al. | 2006 | Female | 44 | TEE | Aortic root reconstruction | Conservative | Survived |
13. Trehan et al. | 2006 | Male | 22 | TTE, MRI, CC | VSD + sinus valsalva repair | Percutaneous | Survived |
14. Martinez et al. | 2007 | Female | 70 | TTE | MVR | Percutaneous | Survived |
15. Martinez et al. | 2007 | Male | 67 | TTE | AVR | Percutaneous | Survived |
16. Uslu et al. | 2007 | Male | 54 | TTE | MVR | Surgery | Survived |
17. Hilberath et al. | 2007 | Male | 68 | TEE | AVR + endocarditis | Surgery | Survived |
18. Frigg et al. | 2008 | Female | 77 | TEE, CC | AVR | Surgery | Survived |
19. Moaref et al. | 2008 | Female | 51 | TEE | MVR | Surgery | na |
20. Aoyagi et al. | 2008 | Female | 71 | TTE, CC | MVR, TV repair | Surgery | Survived |
21. Rothman et al. | 2008 | Male | 86 | TTE, CC | MVR | Percutaneous | Survived |
22. Hansalia et al. | 2009 | Female | 46 | TTE | AVR | Surgery | Survived |
23. Yared et al. | 2009 | Male | 60 | TTE, TTE | AVR+ endocarditis | na | na |
24. Gorki et al. | 2009 | Female | 69 | na | AVR + endocarditis | na | na |
25. Subramaniam et al. | 2009 | Male | 60 | TEE, CT | AVR | Surgery | Survived |
26. Amirghofran et al. | 2009 | Female | 51 | TEE | MVR | Surgery | Survived |
27. Silbiger et al. | 2009 | Female | 30 | TTE, CC | VSD repair | Conservative | Survived |
28. Cheema et al. | 2009 | Female | 31 | MRI | VSD repair | Conservative | Survived |
29. Can et al. | 2009 | Male | 72 | TTE | AV nod ablation | Conservative | Survived |
30. Can et al. | 2009 | Male | 68 | Autopsy | AV nod ablation | na | Died |
31. Dadkhah et al. | 2009 | Female | 73 | TEE | TV repair | Conservative | Survived |
32. Mohapatra et al | 2009 | Female | 22 | TEE | MVR (RF) | Surgery | Survived |
33. Sun et al. | 2010 | na | na | na | MVR | Surgery | na |
34. Sun et al. | 2010 | na | na | na | MVR | na | na |
35. Pursnani et al. | 2010 | Male | 78 | TTE, TEE | AVR | Surgery | Survived |
36. Sharma et al. | 2011 | Male | 80 | TTE | AV nod ablation | Conservative | Survived |
37. Kumar et al. | 2011 | Female | 59 | TEE | AVRx2 + endocarditis | Surgery | Survived |
38. Zhu et al. | 2012 | Baby | 6 months | TTE, TEE | ASD, VSD repair | Percutaneous | Survived |
39. Bochard-Villanueva | 2012 | Male | 63 | TEE, CT | AVR+ endocarditis | Surgery | Survived |
40. Vallakati et al. | 2012 | Female | 53 | TTE | AVR | Conservative | Survived |
41. Elmistekawy et al. | 2012 | Male | 59 | TEE | AVR | Surgery | Survived |
42. Dores et al. | 2012 | Male | 50 | TTE, TEE | AVR, MVR | Surgery | Survived |
43. Yurdakul et al. | 2012 | Male | 68 | TEE | AVR | Surgery | Survived |
44. Mousavi et al. | 2012 | Female | 76 | TEE, MRI | AVR | Conservative | Survived |
45. Ozdogan et al. | 2012 | Female | 31 | TTE, TEE | MVRx2 + endocarditis | Surgery | Died |
46. Anderson et al. | 2012 | na | na | na | AVR | na | na |
47. Toprak et al. | 2013 | Male | 32 | TTE, TEE | AVR | Conservative | Survived |
48. Notarangelo et al. | 2013 | n.a. | 69 | TTE, TEE | MVR | Percutaneous | Survived |
49. Sinisalo et al. | 2013 | Male | 75 | TTE, TEE, CC | AVR | Percutaneous | Survived |
50. Sinisalo et al. | 2013 | Female | 23 | TEE, CC | VSD repair | Percutaneous | Survived |
51. Sinisalo et al. | 2013 | Male | 10 | TEE, CC | ASD, VSD repair | Percutaneous | Survived |
52. Sinisalo et al. | 2013 | Male | 8 | TEE, CC | VSD repair | Percutaneous | Survived |
53. Dangol et al. | 2013 | Male | 6 months | TTE,TEE,CC | ToF repair | Percutaneous | Survived |
54. Lee et al. | 2013 | Male | 3 months | TTE, CC | ASD, PDA, VSD repair | Percutaneous | Survived |
55. Poulin et al. | 2013 | Female | 75 | TTE,TEE | MVR | Percutaneous | Survived |
56. Primus et al. | 2013 | Female | 76 | TTE,TEE | AVR | Conservative | Survived |
57. Chaturvedi et al. | 2013 | Male | 62 | TTE, MRI | AVR | Percutaneous | Survived |
58. Tayama et al. | 2014 | Male | 75 | TTE, CC | MV and TV repair | Surgery | Survived |
59. Hussain et al. | 2014 | Male | 45 | TTE, TEE | AVRx2 | Surgery | Survived |
60. Chamsi-Pasha et al | 2014 | Male | 67 | TTE, TEE | MVR, TVR | Surgery | Survived |
61. Taskesen et al. | 2014 | Male | 74 | TTE, TEE | AVRx2 | Percutaneous | Survived |
62. Fanari et al | 2015 | Female | 50 | TTE, CT | AVR | Percutaneous | Survived |